Please try another search
For the three months ended 31 March 2017, Spectranetics Corp revenues increased 11% to $69.7M. Net loss increased 7% to $18.5M. Revenues reflect Operating Segment-U.S.Medical increase of 10% to $58.4M, Operating Segment-International Medical increase of 14% to $11.3M, U. S. Medical segment increase of 10% to $58.4M, International Medical segment increase of 14% to $11.3M.
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Revenue | 74.71 | 69.68 | 71.93 | 68.27 |
Gross Profit | 56.23 | 51.63 | 53.55 | 51.38 |
Operating Income | -21.29 | -14.98 | -8.55 | -9.86 |
Net Income | -24.6 | -18.52 | -12.61 | -13.31 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Total Assets | 433.35 | 415.74 | 430.08 | 431.86 |
Total Liabilities | 392.16 | 355.28 | 355.75 | 348.95 |
Total Equity | 41.19 | 60.45 | 74.32 | 82.91 |
Period Ending: | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
---|---|---|---|---|
Period Length: | 0 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -14.09 | -24.43 | -20.2 | |
Cash From Investing Activities | -1.71 | -5.35 | -3.87 | |
Cash From Financing Activities | 2.49 | 2.37 | -1.68 | |
Net Change in Cash | -13.29 | -27.36 | -25.7 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review